Wells Fargo & Company United Therapeutics Corp Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in United Therapeutics Corp stock. As of the latest transaction made, Wells Fargo & Company holds 76,270 shares of UTHR stock, worth $27.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
76,270
Previous 76,215 0.07%
Holding current value
$27.5 Million
Previous $27.3 Million 1.46%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$348.66 - $410.0 $19,176 - $22,550
55 Added 0.07%
76,270 $26.9 Million
Q3 2024

Nov 13, 2024
SELL
$311.04 - $363.55 $2.78 Million - $3.25 Million
-8,932 Reduced 10.49%
76,215 $27.3 Million
Q2 2024

Aug 13, 2024
BUY
$228.26 - $319.04 $4.95 Million - $6.92 Million
21,684 Added 34.17%
85,147 $27.1 Million
Q1 2024

May 10, 2024
BUY
$210.76 - $249.51 $3.42 Million - $4.05 Million
16,239 Added 34.39%
63,463 $14.6 Million
Q4 2023

Feb 09, 2024
SELL
$214.88 - $256.94 $1.56 Million - $1.87 Million
-7,281 Reduced 13.36%
47,224 $10.4 Million
Q3 2023

Nov 13, 2023
BUY
$211.82 - $248.24 $187,672 - $219,940
886 Added 1.65%
54,505 $12.3 Million
Q2 2023

Aug 15, 2023
BUY
$205.19 - $232.99 $14,978 - $17,008
73 Added 0.14%
53,619 $11.8 Million
Q1 2023

May 12, 2023
BUY
$212.99 - $276.17 $939,285 - $1.22 Million
4,410 Added 8.98%
53,546 $12 Million
Q4 2022

Feb 13, 2023
SELL
$205.95 - $280.43 $5.04 Million - $6.87 Million
-24,494 Reduced 33.27%
49,136 $13.7 Million
Q3 2022

Nov 14, 2022
BUY
$203.3 - $244.17 $1.68 Million - $2.02 Million
8,263 Added 12.64%
73,630 $15.4 Million
Q2 2022

Aug 12, 2022
SELL
$174.81 - $241.14 $6.03 Million - $8.31 Million
-34,480 Reduced 34.53%
65,367 $15.4 Million
Q1 2022

May 16, 2022
BUY
$166.16 - $213.96 $2.98 Million - $3.83 Million
17,915 Added 21.87%
99,847 $17.9 Million
Q4 2021

Feb 14, 2022
SELL
$184.32 - $216.08 $64.5 Million - $75.7 Million
-350,171 Reduced 81.04%
81,932 $17.7 Million
Q3 2021

Nov 15, 2021
BUY
$179.86 - $214.88 $28.1 Million - $33.6 Million
156,299 Added 56.67%
432,103 $79.8 Million
Q2 2021

Aug 16, 2021
SELL
$170.47 - $211.93 $11.7 Million - $14.6 Million
-68,786 Reduced 19.96%
275,804 $49.5 Million
Q1 2021

May 13, 2021
BUY
$153.94 - $174.85 $6.14 Million - $6.97 Million
39,864 Added 13.08%
344,590 $57.6 Million
Q4 2020

Feb 09, 2021
SELL
$101.87 - $151.79 $3.16 Million - $4.71 Million
-31,047 Reduced 9.25%
304,726 $46.3 Million
Q3 2020

Nov 05, 2020
SELL
$99.9 - $121.13 $9.16 Million - $11.1 Million
-91,656 Reduced 21.44%
335,773 $33.9 Million
Q2 2020

Aug 13, 2020
BUY
$92.74 - $125.82 $34.7 Million - $47.1 Million
374,621 Added 709.4%
427,429 $51.7 Million
Q1 2020

May 14, 2020
BUY
$79.39 - $115.35 $4.19 Million - $6.09 Million
52,808 New
52,808 $5.01 Million

Others Institutions Holding UTHR

# of Institutions
723
Shares Held
60.9M
Call Options Held
123K
Put Options Held
104K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email